Our Company

OUR BUSINESS

Osmotica's business is to develop and commercialize a proprietary portfolio of neurology based products while leveraging our extensive technology platforms through select drug development programs with partners.

The Company is currently developing numerous products related to Central Nervous System disorders with a focus in Parkinson's disease and related neurological disorders. Our technology platforms also enable us to pursue development of other challenging products for our partners. This aspect of our business includes internally developed products for future licensing and co-development programs supporting our partners' proprietary molecules.